Hepatitis B virus treatment in hepatocellular carcinoma patients prolongs survival and reduces the risk of cancer recurrence

Chronic hepatitis B virus (HBV) infection and HBV-related liver disease are estimated to affect about 240 million people worldwide. Now that a vaccine is available, the number of new HBV infection cases has plummeted. Yet, there are still regions with very high incidence of HBV. Hepatocellular carci...

Descripción completa

Detalles Bibliográficos
Autores principales: Pazgan-Simon, Monika, Simon, Krzysztof A., Jarowicz, Ewa, Rotter, Katarzyna, Szymanek-Pasternak, Anna, Zuwała-Jagiełło, Jolanta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2018
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185928/
https://www.ncbi.nlm.nih.gov/pubmed/30324148
http://dx.doi.org/10.5114/ceh.2018.78127

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6185928/
https://www.ncbi.nlm.nih.gov/pubmed/30324148
http://dx.doi.org/10.5114/ceh.2018.78127

Ejemplares similares